Twenty nineteen was expected to be a challenging year for monoethylene glycol (MEG) sellers, given the increased global capacity, but many failed to envisage how quickly prices and margins would be impacted.
The market certainly has fallen in favour of buyers, as MEG has gone from being one of the top performing European ethylene-based derivatives, to the worst in twelve months.
Find out more in this market insight by Melissa Hurley